Dihydroergotamine Mesylate and Treprostinil Extended-Release Tablets
Determining the interaction of Dihydroergotamine Mesylate and Treprostinil Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: treprostinil
Brand name: Orenitram, Remodulin, Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit
Synonyms: Treprostinil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Treprostinil inhalation
- Dihydroergotamine Mesylate-Treprostinil injection
- Dihydroergotamine Mesylate-Treprostinil Injection Solution
- Dihydroergotamine Mesylate-Treprostinil Oral Inhalation Solution
- Dihydroergotamine Mesylate-Treprostinil Sodium
- Dihydroergotamine Mesylate-Tresiba
- Treprostinil Extended-Release Tablets-Dihydroergotamine nasal
- Treprostinil Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Treprostinil Extended-Release Tablets-Dilacor XR
- Treprostinil Extended-Release Tablets-Dilantin
- Treprostinil Extended-Release Tablets-Dilantin Infatabs
- Treprostinil Extended-Release Tablets-Dilantin injection